Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Core Viewpoint - Milestone Pharmaceuticals Inc. is set to report its fourth-quarter earnings on March 20, with analysts predicting a loss of 16 cents per share and revenue of $1.20 million [1]. Group 1: Earnings Report - The company will release its earnings before the market opens on March 20 [1]. - Analysts expect a quarterly loss of 16 cents per share [1]. - Projected revenue for the quarter is $1.20 million [1]. Group 2: Management Changes - On February 10, Milestone Pharmaceuticals appointed David Sandoval as general counsel and chief compliance officer [1]. Group 3: Stock Performance - Shares of Milestone Pharmaceuticals closed at $1.70 on the preceding Thursday [1].